C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/775 (2006.01) A01K 67/027 (2006.01) C12N 5/10 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2236274
Recombinant apolipoprotein E2 (apoE2) which binds to amyloid peptide A.beta..
L'invention concerne l'apolipoprotéine E2 (apoE2) de recombinaison qui se fixe au peptide amyloïde A.beta..
Aleshkov Sergei B.
Zannis Vassilis I.
Kos Life Sciences Inc.
Kos Pharmaceuticals Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Trustees Of Boston University
LandOfFree
Apolipoprotein e2 and treatment of alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apolipoprotein e2 and treatment of alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apolipoprotein e2 and treatment of alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1447733